Hyundai Cancer Institute
::
Leukemia Treatment Program
The Leukemia Treatment Program at the Hyundai Cancer Institute at CHOC Children's is made up of a team of highly trained leukemia specialists dedicated to providing compassionate, family-centered care. Divided into two specific treatment teams, our experts can treat all forms of leukemia:
- The Standard/High Risk Leukemia Team treats patients with standard to high-risk acute lymphoblastic leukemia (ALL).
- The Very High Risk Leukemia/Bone Marrow Transplant Team treats all patients with very-high-risk ALL and acute myeloid leukemia (AML). This team also works with patients receiving blood and marrow transplants through the Cancer Institute’s Blood and Marrow Transplant Program.
Our Leukemia Treatment Program adapts the most effective protocols available to suit the disease needs of each patient, while focusing on the social and emotional needs of the patient and family. We know that a cancer diagnosis can be stressful and frightening; our treatment teams are dedicated to providing the care, support, compassion and open communication patients and families need.
- Acute Lymphoblastic Leukemia (ALL), both B and T cell
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Chronic Myelogenous Leukemia (CML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Myelodysplastic Syndrome (MDS)
- Transient Myeloproliferative Disorders (TMD)
Leukemia Patient and Family Resources
Because we understand that a leukemia diagnosis can be very overwhelming, the Leukemia Treatment Program has put together a list of frequently asked questions and answers. You may find this document handy as you speak to friends and family about leukemia.
Clinical Trials
Children’s cancers are very different than adult cancers and must be treated with specific pediatric cancer protocols. Our experience in exclusively treating children, teens, and young adults makes us the experts in the evaluation and treatment of all forms of common childhood and adolescent cancers. A majority of our protocols come from the Children’s Oncology Group (COG), a national organization funded by the National Cancer Institute (NCI). We are the only hospital in the region to offer COG Phase I clinical trials. Learn more about our clinical trials.











